All of the following are B cell markers except:
B cells are identified by specific surface proteins. CD19, CD20, and CD22 are well-known B cell markers. CD19 is crucial for B cell activation and signaling. CD20 is targeted by drugs like rituximab. CD22 is another surface receptor involved in B cell function.
Now, the question is about the exception. The options are missing, but common distractors could be T cell markers like CD3 or CD4, or maybe other markers like CD45 (which is on all leukocytes) or CD14 (a monocyte marker). Let's assume the options are CD19, CD20, CD3, and CD22. The correct answer would be CD3, as it's a T cell marker.
I need to explain why CD3 is not a B cell marker. CD3 is part of the T cell receptor complex, essential for T cell activation. B cells don't express CD3. The other options are B cell markers. The clinical pearl here is to remember that B cell markers include CD19, CD20, CD22, while CD3 is T cell specific. That's a key point for exams.
**Core Concept**
B cells are identified by specific surface immunoglobulin markers and accessory proteins. Key markers include CD19, CD20, CD22, and surface immunoglobulins like IgM or IgD. T cell markers (e.g., CD3) or pan-leukocyte markers (e.g., CD45) are not B cell-specific.
**Why the Correct Answer is Right**
CD3 is a T cell-specific marker, part of the T cell receptor complex essential for antigen recognition and activation. B cells do not express CD3, making it the correct exception. This distinction is critical for immunophenotyping in conditions like leukemias.
**Why Each Wrong Option is Incorrect**
**Option A:** CD19 is a B cell-specific marker involved in BCR signaling.
**Option B:** CD20 is a B cell surface protein targeted by monoclonal antibodies like rituximab.
**Option C:** CD22 is a B cell receptor that mediates adhesion and signaling.
**Clinical Pearl**
Remember: **B cells = CD19 + CD20 + CD22**; **T cells = CD3 + CD4/CD8**. CD3 is never expressed on mature B cells. This distinction is vital for diagnosing lymphomas (e.g., B-cell vs. T-cell lymphoblastic leukemia).
**Correct Answer: D. CD3**